rofecoxib has been researched along with Kaposi Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coras, B | 1 |
Hafner, C | 1 |
Reichle, A | 1 |
Hohenleutner, U | 1 |
Szeimies, RM | 1 |
Landthaler, M | 1 |
Vogt, T | 1 |
1 other study available for rofecoxib and Kaposi Sarcoma
Article | Year |
---|---|
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
Topics: Adult; Angiogenesis Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Endemic Diseases; Human | 2004 |